Premium
Isolation and characterization of epithelial progenitor cells from human fetal liver
Author(s) -
Liu YiNan,
Zhang Jun,
He QiHua,
Dai Xin,
Shen Li
Publication year - 2008
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/j.1872-034x.2007.00163.x
Subject(s) - progenitor cell , isolation (microbiology) , fetus , progenitor , biology , stem cell , pathology , medicine , microbiology and biotechnology , bioinformatics , genetics , pregnancy
Aim: Hepatic progenitor cells can serve as an alternative source of hepatocytes for the treatment of liver diseases. Methods: We isolated and expanded the epithelial progenitor cells (EPC) from the human fetal liver and investigated the differentiation of EPC into hepatic cells by fluorescence‐activated cell sorter (FACS), real‐time polymerase chain reaction (PCR), immunofluorescence assay, western blotting, and periodic acid–Schiff staining. Results: Isolated EPC possessed highly proliferative ability and subpassaged for more than 25 passages. Real‐time PCR showed that EPC expressed liver epithelial markers (cytokeratin [CK]8 and CK18) and biliary‐specific markers (CK7 and CK19). FACS analysis indicated that these cells were positive for CD117, CD147, CD90, CD44, human leucocyte antigen class I and CD71, but negative for CD34 and CD45. The EPCpossessed multipotential indicated by differentiating into osteoblasts and adipocytes; when subjected to the hepatic differentiation condition, EPC could be induced to hepatocyte‐like cells, which expressed albumin, alpha‐fetoprotein, and CK18 proteins. Two months after EPC transplantation, we observed that the grafted cells differentiated into hepatocyte‐like cells and there was no observable tumor mass. Conclusion: We have isolated and characterized the human fetal liver‐derived EPC and these cells may serve as an ideal cell source for cell‐replacement therapy of diseased livers.